Tailoring Risperidone-Loaded Glycethosomal In Situ Gels Using Box–Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route

Schizophrenic patients often face challenges with adherence to oral regimens. The study aimed to highlight the potentiality of intranasal ethanol/glycerin-containing lipid-nanovesicles (glycethosomes) incorporated into in situ gels for sustaining anti-psychotic risperidone (RS) release. The Box–Behn...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdallah, Marwa H., El-Horany, Hemat El-Sayed, El-Nahas, Hanan M., Ibrahim, Tarek M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675145/
https://www.ncbi.nlm.nih.gov/pubmed/38004501
http://dx.doi.org/10.3390/pharmaceutics15112521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675145/
https://www.ncbi.nlm.nih.gov/pubmed/38004501
http://dx.doi.org/10.3390/pharmaceutics15112521

Ejemplares similares